Projects and Grants per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Post Doctoral Fellow, University Of S Carolina - Charleston
2015
Doctor of Philosophy, University Of Kentucky
2010
Master of Science, University Of Kentucky
2007
Bachelor of Science, University Of California - San Diego
2004
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Neuroimmune and Cognitive Consequences of Nicotine Use in a Rodent Model of HIV: Implications for Anti-Retroviral Therapies
Gipson-Reichardt, C. (PI) & Zentall, T. (CoI)
National Institute on Drug Abuse
9/30/24 → 8/31/26
Project: Research project
-
Neurobehavioral Mechanisms Underlying Xylazine and Fentanyl Co-use and Withdrawal
Gipson-Reichardt, C. (PI), Moseley, H. (CoI), Prisinzano, T. (CoI) & Hinds, T. (CoPI)
National Institute on Drug Abuse
6/15/23 → 4/30/28
Project: Research project
-
Contributions of Progestins Independently and Interactively with Contraceptive Estrogen to Nicotine Use
Gipson-Reichardt, C. (PI) & Beckmann, J. (CoI)
National Institute on Drug Abuse
9/30/22 → 8/31/25
Project: Research project
-
Glutamergic Mechanisms in Opioid and Cocaine Co-Use
Gipson-Reichardt, C. (PI), Anderson, D. (CoI), Hatton, K. (CoI), Hays, L. (CoI), Lile, J. (CoI), Wesley, M. (CoI), Stoops, W. (CoPI), Rayapati, A. (Former CoI) & Rush, C. (Former CoI)
National Institute on Drug Abuse
9/30/20 → 8/31/25
Project: Research project
-
Neuroinflammatory and Glutamatergic Mechanisms of Nicotine Seeking
Gipson-Reichardt, C. (PI)
National Institute on Drug Abuse
9/1/20 → 8/31/25
Project: Research project
-
Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options
Corley, C., Craig, A., Sadek, S., Marusich, J. A., Chehimi, S. N., White, A. M., Holdiness, L. J., Reiner, B. C. & Gipson, C. D., Oct 2024, In: Pharmacology Biochemistry and Behavior. 243, 173836.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: A comparison to lofexidine
Sadek, S. M., Khatri, S. N., Kipp, Z., Dunn, K. E., Beckmann, J. S., Stoops, W. W., Hinds, T. D. & Gipson, C. D., Mar 1 2024, In: Neuropharmacology. 245, 109816.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl
Gipson, C. D. & Strickland, J. C., Jan 2024, In: Neuropsychopharmacology. 49, 1, p. 319-320 2 p.Research output: Contribution to journal › Comment/debate
2 Scopus citations -
Novel psychoplastogen DM506 reduces cue-induced heroin-seeking and inhibits tonic GABA currents in the Prelimbic Cortex
Looschen, K., Khatri, S. N., Maulik, M., Salisbury, C., Carman, A. F., Corriveau, K., Smith, C., Manetti, D., Romanelli, M. N., Arias, H. R., Gipson, C. D. & Mitra, S., Sep 2024, In: Neurochemistry International. 178, 105785.Research output: Contribution to journal › Article › peer-review
-
Opioid craving does not incubate over time in inpatient or outpatient treatment studies: Is the preclinical incubation of craving model lost in translation?
Bergeria, C. L., Gipson, C. D., Smith, K. E., Stoops, W. W. & Strickland, J. C., May 2024, In: Neuroscience and Biobehavioral Reviews. 160, 105618.Research output: Contribution to journal › Review article › peer-review
5 Scopus citations